V. Shah

Risk factors for breast cancer from benign breast disease in a diverse population

A. Kapke, M. Worsham, U. Raju, 2009, Breast Cancer Research and Treatment.

Feasibility of 4 cycles of docetaxel and cyclophosphamide every 14 days as an adjuvant regimen for breast cancer: a Wisconsin Oncology Network study.

M. Burkard, KyungMann Kim, A. Tevaarwerk, 2014, Clinical Breast Cancer.

Abstract P3-12-10: Feasibility of four cycles of docetaxel and cyclophosphamide every 14 days as an adjuvant regimen for breast cancer: A Wisconsin oncology network study

M. Burkard, KyungMann Kim, A. Tevaarwerk, 2013 .

False‐negative core needle biopsies of the breast

V. Deshpande, D. Chitale, U. Raju, 2003, Cancer.

MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial

G. Srkalović, W. Audeh, H. Soliman, 2020, BMC Cancer.

MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial

G. Srkalović, W. Audeh, H. Soliman, 2020, BMC Cancer.